PI Publications
- 2025An international Phase IV field study - psychometric properties of the updated module on assessing quality of life of patients with breast cancer EORTC QLQ-BR42. The Breast. PMID: 39947087
Bjelic- Radisic V, Cardoso F, Weis J....Nookala M...Duhoux F...etal. on behalf of the EORTC Quality of Life Group and Breast Cancer Group
- 2024Correlation of the geriatric assessment with overall survival in older patients with cancer. Clinical Oncology. 36(1): e61-e71PMID: 37953073
Rao A, Noronha V, Ramaswamy A, Kumar A, Pillai A, Gattani S, Sehgal A, Kumar S, Castelino R, Dhekle R, Krishnamurthy J, Mahajan S, Daptardar A, Sonkusare L, Deodhar J, Ansari N, Vagal M, Mahajan P, Timmanpyati S, Nookala M, Chitre A, Kapoor A, Gota V, Banavali S, Badwe R, Prabhash K
Assessing frailty in older Indian patients before cancer treatment: Comparative analysis of three scales and their implications for overall survival. Journal of Geriatric Oncology. 15(3):101736. PMID: 38428186.Rao AR, Noronha V, Ramaswamy A, Kumar A, Pillai A, Sehgal A, Castelino R, Dhekale R, Jagtap P, Tripathi V, Satamkar S, Krishnamurthy J, Mahajan S, Daptardar A, Sonkusare L, Deodhar J, Ansari N, Vagal M, Mahajan P, Timmanpyati S, Nookala M, Chitre A, Kapoor A, Gota V, Banavali S, Badwe RA, Prabhash K
An analysis of psychological problems in older Indian patients with cancer. Journal of Geriatric Oncology. 15(4):101744. PMID: 38538494Kumar A, Sonkusare L, Noronha V, Deodhar J, Rao A, Kumar S, Castellino R, Gattani S, Dhekale R, Krishnamurthy J, Mahajan S, Daptadar A, Ansari N, Vagal M, Gota V, Mahajan P, Nookala M, Chitre A, Banavali S, Prabhash K, Ramaswamy A
- 2023The current status of geriatric oncology in India. Ecancer. 17:1595. PMID: 37799956
Noronha V, Rao AR, Ramaswamy A, Kumar A, Pillai A, Dhekale R, Krishnamurthy J, Kapoor A, Gattani S, Sehgal A, Kumar S, Castelino R, Mahajan S, Daptardar A, Sonkusare L, Deodhar J, Ansari N, Vagal M, Mahajan P, Timmanpyati S, Nookala M, Chitre A, Narasimhan PN, Banerjee J, Gota V, Banavali S, Badwe R, Prabhash K
- 2022Feasibility of therapeutic drug monitoring of sunitinib and its implications on response and toxicity in patients with metastatic renal cell cancer. Cancer Chemotherapy Pharmacology. 89(6):751-759. PMID: 35441269.
Gandhi KA, Joshi A, Mehta P, Gurjar M, Rane P, Sharma J, Patil A, Nookala M, Noronha V, Prabhash K, Gota V
- 2021Effect of body mass index on pharmacokinetics of paclitaxel in patients with early breast cancer. Cancer Medicine. 10(9): 3068-3076. PMID: 33826243
Gota V, Nookala M, Bonda A, Karanam A, Shriyan B, Kembhavi Y, Gurjar M, Patil A, Singh A, Goyal N, Gupta S
ADME gene polymorphisms do not influence the pharmacokinetics of docetaxel: Results from a population pharmacokinetic study in Indian cancer patients. Cancer Medicine. 10:4948–4956. PMID: 34156160Patil A, Shriyan B, Mehta P, Patil M, Gurjar M, Nookala M, Patil V, Joshi A, Noronha V, Prabhash K, Gota V
- 2020An HPLC method for simultaneous quantification of sunitinib and its active metabolite, SU12662, using hydrophilic interaction chromatography principle. Bioanalysis. 12(2): 75-85. PMID: 31928228
Gurjar M, Mehta P, Sharma J, Patil S, Kulkarni P, Patil A, Nookala M, Joshi A, Gota V
Clinical pharmacokinetics of 3-h extended infusion of meropenem in adult patients with severe sepsis and septic shock: implications for empirical therapy against Gram-negative bacteria. Annals of Intensive Care. 10(1): 4. PMID: 31925610Kothekar A, Divatia JV, Myatra SN, Patil A, Nookala Krishnamurthy, M, Maheshwarappa HM, Siddiqui SS, Gurjar M, Biswas S, Gota V
Safety and CSF distribution of high-dose erlotinib and gefitinib in patients with non-small cell lung cancer (NSCLC) with brain metastases. European Journal of Clinical Pharmacology. 76(10):1427-1436. PMID: 32529316Shriyan B, Patil D, Gurjar M, Nookala M, Patil A, Kannan S, Patil V, Joshi A, Noronha V, Prabhash K, Gota V